Overview

The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial

Status:
Completed
Trial end date:
2002-10-01
Target enrollment:
Participant gender:
Summary
The HOME-trial is a prospective, randomized controlled trial. The purpose of this study is to investigate the effects of metformin HCL in patients with type 2 diabetes mellitus intensively treated with insulin on the quality of the metabolic control of diabetes, the daily dose of insulin, the lipid profile, the blood pressure, the incidence / progression of microvascular and macrovascular complications, and on the qualify of life (Diabetes Health Profile). Early results had been published in Diabetes Care, December 2002, pages 2133-2140.
Phase:
Phase 3
Details
Lead Sponsor:
Bethesda General Hospital, Hoogeveen
Collaborators:
Dupont Merck
LifeScan
Merck KGaA
Merck KGaA, Darmstadt, Germany
Merck Sharp & Dohme Corp.
Novo Nordisk A/S
Takeda
Treatments:
Insulin
Insulin, Globin Zinc
Metformin